KELLY BARRIAULT: Open Payments
NPI 1164492138 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 53 payments from 14 companies in 2025. Trend: 2023 $129 · 2024 $546 · 2025 $1,287
Food & beverage: $1,187Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $250 |
| ABBVIE INC. | 12 | $228 |
| Novartis Pharmaceuticals Corporation | 6 | $167 |
| Amgen Inc. | 3 | $161 |
| UCB, Inc. | 5 | $116 |
| GENZYME CORPORATION | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Incyte Corporation | 2 | $52 |
| Genentech USA, Inc. | 1 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
Products named: TREMFYA, OTEZLA, DUPIXENT, SKYRIZI, Bimzelx, RINVOQ, Rhapsido, OPZELURA.
Industry payments across VA — which companies pay providers there.
